Variant report
Variant | nsv997579 |
---|---|
Chromosome Location | chr3:66011-87967 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:84119..86199-chr3:87586..89599,2 | K562 | blood: | |
2 | chr3:84468..85168-chr3:395782..396503,2 | MCF-7 | breast: | |
3 | chr3:84119..86199-chr3:87586..89599,2 | K562 | blood: | |
4 | chr3:86365..87356-chr3:395941..396726,2 | MCF-7 | breast: | |
5 | chr3:84540..85233-chr3:395143..396665,5 | MCF-7 | breast: | |
6 | chr3:84682..85249-chr3:418773..419384,2 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CHL1-2 | chr3:65642-66175 | XLOC_002562 |
2 | lnc-CHL1-4 | chr3:86531-87048 | l_2300_chr3:84309-87048_testes |
3 | lnc-CHL1-4 | chr3:84310-84695 | l_2300_chr3:84309-87048_testes |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541078741 | chr3:66014-66015 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs149311860 | chr3:66049-66050 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs535792839 | chr3:66074-66075 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs557283565 | chr3:66078-66079 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs9713920 | chr3:66083-66084 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs539211631 | chr3:66107-66108 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs574859468 | chr3:66143-66144 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs112617705 | chr3:66160-66161 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs35007339 | chr3:66164-66165 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs545839864 | chr3:74419-74420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs564053938 | chr3:74436-74437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528434641 | chr3:74460-74461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527773328 | chr3:74463-74464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568172730 | chr3:74503-74504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112795193 | chr3:74506-74507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187780632 | chr3:74513-74514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144312387 | chr3:74518-74519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537134807 | chr3:74523-74524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11128710 | chr3:74573-74574 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs570508914 | chr3:74625-74626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs534988229 | chr3:74628-74629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs553590658 | chr3:74634-74635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191644857 | chr3:74655-74656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369099588 | chr3:74666-74667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs542378162 | chr3:74682-74683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557247718 | chr3:74707-74708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11128717 | chr3:74710-74711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs140133456 | chr3:74723-74724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143682940 | chr3:74725-74726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73813990 | chr3:74734-74735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540175665 | chr3:74747-74748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9713456 | chr3:74748-74749 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs146345700 | chr3:74767-74768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184112616 | chr3:74790-74791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188858453 | chr3:75220-75221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532921112 | chr3:75229-75230 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs147604496 | chr3:75244-75245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564213103 | chr3:75266-75267 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs73093442 | chr3:75276-75277 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs75301107 | chr3:75288-75289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181610241 | chr3:75290-75291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs185398643 | chr3:75306-75307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573853076 | chr3:75307-75308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190643164 | chr3:75325-75326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551257113 | chr3:75332-75333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13326968 | chr3:75351-75352 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs540013875 | chr3:75358-75359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs13066179 | chr3:75375-75376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142209918 | chr3:75380-75381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs116969138 | chr3:75387-75388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Lung cancer | 16618734 | CNVD |
Autism | 18349135 | CNVD |
Breast cancer | 20409316 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Intellectual disability | 22045946 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Mental retardation | 17124404 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20967226 | CNVD |
Autism | 22543975 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Ependymoma | 20639864 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:74400-74800 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
2 | chr3:75200-75800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr3:84000-84400 | Enhancers | Fetal Brain Male | brain |
4 | chr3:84200-84600 | Enhancers | Fetal Brain Female | brain |
5 | chr3:84400-85400 | Weak transcription | Fetal Brain Male | brain |
6 | chr3:84800-85200 | Enhancers | Brain Germinal Matrix | brain |
7 | chr3:84800-85200 | Active TSS | Fetal Brain Female | brain |
8 | chr3:84800-85400 | Enhancers | Liver | Liver |
9 | chr3:85200-85800 | Enhancers | Fetal Brain Female | brain |
10 | chr3:85200-85800 | Enhancers | HepG2 | liver |
11 | chr3:85400-86000 | Flanking Active TSS | Liver | Liver |
12 | chr3:85400-86200 | Enhancers | Fetal Brain Male | brain |
13 | chr3:85600-85800 | Flanking Active TSS | Gastric | stomach |
14 | chr3:85600-86000 | Bivalent Enhancer | Fetal Kidney | kidney |
15 | chr3:85800-86000 | ZNF genes & repeats | Gastric | stomach |
16 | chr3:85800-86200 | Flanking Active TSS | HepG2 | liver |
17 | chr3:86000-86800 | Enhancers | Liver | Liver |
18 | chr3:86200-86800 | Enhancers | HepG2 | liver |
19 | chr3:86800-87800 | Weak transcription | HepG2 | liver |